MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161
Published July 13, 2016 · Recall initiated: August 21, 2015
Summary
FDA records drug Class II recall D-1164-2016, published July 13, 2016 and initiated August 21, 2015. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: 1570 syringes; Lot: Lot: 6178, exp, 9/12/15; 6529, exp 11/22/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cantrell Drug Company
- Distributor
- Nationwide
- UPC
- 01003525330011
- Lot
- Lot: 6178, exp, 9/12/15; 6529, exp 11/22/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEphedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
- FDAGlycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell DrugAugust 16, 2017
- FDAPhenylephrine HCL in 0.9% Sodium Chloride 10 mL, 1 mg/10 mL (100 mcg/mL) Single-Dose Syringe, Rx Only,August 16, 2017
- FDANeostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
- FDAMidazolam HCl in 0.9% Sodium Chloride Injection, 0.5 mg/mL 1 mL (0.5 mg/mL), 1 mL syringes, Rx Only, CantrellJuly 13, 2016
- FDAZero Xtreme High Performance Fat Burner capsules, 30-count bottle, Distributed by Xtreme Z Distributors, Inc.,July 13, 2016
Questions about this recall
Was MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161 recalled?
Yes. FDA published recall D-1164-2016 on July 13, 2016. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. UPC: 01003525330011.